How much funding has Soley Therapeutics raised?

Soley Therapeutics has raised $295.0M in total funding, most recently a Series C round.

Who are Soley Therapeutics's investors?

Soley Therapeutics's investors include Breyer Capital, Surveyor Capital, HRTG Partners, RWN Management, GordonMD Global Investments.

When was Soley Therapeutics founded?

Soley Therapeutics was founded in 2020.

Where is Soley Therapeutics headquartered?

Soley Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Soley Therapeutics in?

Soley Therapeutics operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Soley Therapeutics have?

Soley Therapeutics has 11-50 employees.

Soley Therapeutics

Biology-First Drug Discovery

South San Francisco, United States · Founded 2020 · $295.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: soleytherapeutics.com
Total Funding: $295.0M
Last Round: $200.0M Series CJan 2026
Rounds: 3

About

Founded in 2020 by UCSF scientists Dr. Yerem Yeghiazarians and Dr. Kurosh Ameri, Soley Therapeutics is a biology-first drug discovery company that uses cell stress sensing to identify first-in-class medicines. The company is building a pipeline spanning oncology, neurodegeneration, and metabolic diseases using proprietary imaging, automation, and AI/ML.

Summary

Soley Therapeutics is an Artificial Intelligence company based in South San Francisco, United States, founded in 2020. It has raised $295.0M in total across 3 rounds, most recently a $200.0M Series C round in Jan 2026. Investors include Breyer Capital, Surveyor Capital and HRTG Partners.